Latest Asx Company Updates News

Regis Healthcare reveals a funding update amid government changes, projecting modest EBITDA growth despite a funding gap and rising wage costs.

Core Energy Minerals has appointed Anthony Greenaway as Managing Director, aiming to leverage his extensive exploration expertise to advance its uranium and rare earth projects in South Australia and Brazil.

Foresta Group Holdings has finalized a $4.6 million insurance settlement related to 2021 asset damage at Apple Tree Creek, marking the close of a multi-year claim process.

Ryder Capital Limited reports a striking 12.75% preliminary gain in its investment portfolio for August 2025, lifting its pre-tax net tangible assets per share to $1.964 before dividend payout.

M3 Mining Limited has announced a significant leadership renewal alongside a strategic review aimed at streamlining operations, reducing costs, and focusing on high-value exploration assets.

Vault Minerals announces that CEO Luke Tonkin will step down within the next 12 months, triggering a leadership transition as the company continues to build on recent operational successes.

Augustus Minerals has appointed Dr James Warren as its new CEO, bringing a wealth of exploration and corporate growth experience to lead its promising Western Australian projects. This leadership change signals a strategic push towards advancing drilling campaigns and unlocking shareholder value.

Investor Centre Limited is progressing a key capital raising while its subsidiary Pulse Markets grows wholesale trading operations, signaling strategic momentum despite modest cash outflows.

Invion Limited has secured a $20,000 grant to support its anogenital cancer trial and progressed its skin cancer study with promising early results, while raising approximately $1 million through a Loyalty Option Entitlement Offer.

CurveBeam AI reported a solid 18% increase in purchase orders for FY25, alongside record cash receipts and positive operational cash flow in Q4. The company is also advancing a significant vendor financing facility to support growth in key markets.

Gullewa Limited reports significant progress in its mining and property ventures, including a major drilling campaign and lot sales, setting the stage for an updated resource estimate.

Invex Therapeutics has broadened its collaboration with Tessara Therapeutics to explore Exenatide’s potential in Alzheimer’s disease, while successfully renewing key orphan drug designations in Europe and the US.